TCTAP A-075 High-Flow Continuous Hemodiafiltration (HF-CHDF) During CAG and PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients with Advanced Chronic Kidney Disease: A Pilot Study

TCTAP A-075 High-Flow Continuous Hemodiafiltration (HF-CHDF) During CAG and PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients with Advanced Chronic Kidney Disease: A Pilot Study

Recently, it was reported that continuous hemofiltration (CHF) could prevent CIN and reduce in-hospital mortality in advanced CKD-patients via both filtrating contrast and administration of alkaline agents.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-05, Vol.65 (17), p.S39-S39
Hauptverfasser: Oyamada, Naofumi, Hamanaka, Ichiro, Fujie, Hiroaki, Ueda, Kinzo
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Hydration
Internal Medicine
Kidney diseases
Medical treatment
Mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Recently, it was reported that continuous hemofiltration (CHF) could prevent CIN and reduce in-hospital mortality in advanced CKD-patients via both filtrating contrast and administration of alkaline agents.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.03.579